Mc Glone Suttner Wealth Management, Inc. Gilead Sciences, Inc. Transaction History
Mc Glone Suttner Wealth Management, Inc.
- $662 Billion
- Q2 2025
A detailed history of Mc Glone Suttner Wealth Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mc Glone Suttner Wealth Management, Inc. holds 4,430 shares of GILD stock, worth $528,986. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,430
Previous 4,062
9.06%
Holding current value
$528,986
Previous $455 Million
7.91%
% of portfolio
0.07%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding GILD
# of Institutions
2,297Shares Held
1BCall Options Held
9.56MPut Options Held
9.96M-
Black Rock Inc. New York, NY121MShares$14.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$14 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.11 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.52 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.39 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...